BKNG has dropped 19% in a month to $171.32, yet short sellers are quietly reducing exposure and the analyst community remains firmly in the bull camp — a divergence between price action and positioning that defines this week's setup.
The short interest story is genuinely striking, though not in the way the price decline might imply. At 62.4% of free float, the headline number looks alarming. The reality is more nuanced: shorts trimmed about 9% of their positions over the past month, and the week-on-week change was a further 0.7% reduction. Borrow conditions reinforce the picture — cost to borrow has fallen 18% over the week to just 0.41%, among the lowest readings of the past 30 days, and availability is essentially unlimited, with the lending pool showing no meaningful pressure. Shorts are not piling in to press the stock lower; if anything, they are stepping back. Options tell a similar story. The put/call ratio at 0.87 is fractionally below its 20-day average of 0.88, well within normal range and showing no evidence of defensive hedging. Overall, positioning looks cautious rather than crowded — a large gross short position, but one that is slowly deflating, not building.
The Street's conviction stands in sharp contrast to recent price weakness. Morgan Stanley assumed coverage this week with an Overweight rating and a $230 target — a firm that matters, and a move that lands while the stock trades at $171. Evercore ISI raised its target to $270 from $245 on August 24. UBS sits at $274. The mean analyst target is $238.78, implying roughly 39% return from current levels, and the analyst recommendation divergence factor scores in the 98th percentile — meaning consensus is more positively skewed than almost every other name in the universe. Bulls point to the Connected Trip strategy growing at a low-double-digit rate in Q2, resilient underlying demand outside the Middle East, and durable FCF conversion. Bears flag the company's reliance on paid customer acquisition and the assumption embedded in management's second-half guidance that Middle East tensions ease — a macro variable the company cannot control. The PE ratio has compressed to 14.5x on a trailing basis, falling about 3.7 points over the past month as the stock has de-rated; EV/EBITDA has eased to 11.1x.
The ownership register shows a mixed but largely passive picture. Capital Research added over 8 million shares in the most recent disclosed period, a meaningful addition for a manager of that size. JP Morgan Asset Management added 233,000 shares to its position. Insiders have been net sellers of approximately $16.9 million over the past 90 days, though every disclosed transaction was executed under a pre-arranged 10b5-1 plan — the mechanical nature of those sales takes the edge off what might otherwise look like an insider signal. Peers were broadly weaker on the week: EXPE bucked the trend with a 6.7% gain, but MMYT fell 11.1%, NCLH dropped 7.2%, and ABNB shed 3.6% — suggesting travel-sector pressure rather than BKNG-specific distress as the driver of this month's move.
The next scheduled earnings event is October 29, with the most recent print — August 4 — delivering a 7.4% next-day gain and 10.5% by the fifth day. The question into Q3 results is whether the Middle East risk embedded in the bear case has materially moved since the August print, and whether the Connected Trip growth trajectory justifies a valuation re-rating back toward the levels analysts are currently defending.
See the live data behind this article on ORTEX.
Open BKNG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
